Stocks-Prognosis.com
Search on StockPrognosis.com
To search on the site stockprognosis.com enter the name of the ticker, company name, or search phrase
Sections of the site



Thermo Fisher Scientific Inc. TMO Anticipates a Promising Future with Business Boost in 2025 and 2026

January 01, 2025
Thermo Fisher Scientific Inc., a leading laboratory equipment and services provider, is expecting a gradual improvement in its business prospects in the coming years. The company's CEO, Jim Cramer, recently expressed his optimism about Thermo Fisher's future growth during an interview with Yahoo Finance. Cramer believes that the company's performance will pick up significantly in 2025 and 2026, driven by a resurgence in demand for its products and services.

Thermo Fisher has a strong track record of delivering innovative solutions to the scientific community across various industries, including healthcare, research, and pharmaceuticals. With its extensive product portfolio, the company is well-positioned to capitalize on emerging trends in precision medicine and genetic research.

Despite the challenges posed by the COVID-19 pandemic, Thermo Fisher has managed to maintain a healthy balance sheet. According to Simply Wall St News, the company has a robust financial position, thanks to its solid revenue streams and efficient cost management.

Investors seeking long-term prospects may consider Thermo Fisher as a potential investment option. Insider Monkey suggests that the company could be one of the best stocks to hold for the next decade. With its strong market presence, continued focus on innovation, and the rising demand for scientific solutions, Thermo Fisher is expected to deliver substantial returns to its shareholders.

For those interested in trading Thermo Fisher stocks, it is recommended to consult with professionals from Stocks Prognosis. Their expertise in analyzing market trends and providing accurate forecast predictions can assist investors in making informed decisions.

In conclusion, Thermo Fisher Scientific Inc. TMO is set to experience a promising future with its business gradually improving in 2025 and 2026. The company's strong financial position, coupled with its market leadership and focus on innovation, makes it an attractive investment opportunity for long-term investors.
If you want to leave a comment, then you need Login or Register





Other data for TMO

Related data

TMOJuly 23, 2025Thermo Fisher Scientific Inc. Hits Price Target Forecast, Generating Profit of 9.73%  ~2 min.

Thermo Fisher Scientific Inc. (TMO) has successfully achieved the price target forecast set by QuantWave, resulting in a profit of 9.73%....


TMOJuly 2, 2025Thermo Fisher Scientific Inc. Hit Price Target Forecast with 9.61% Profit, QuantWave Analysis Shows Strong Predictive Power  ~1 min.

Thermo Fisher Scientific Inc. (NYSE: TMO) recently reached a price target forecast set by QuantWave, an automated forecasting platform, with a profit of 9.61%....


TMOJune 30, 2025Thermo Fisher Scientific Inc. TMO: A Bull Case Theory  ~1 min.

Thermo Fisher Scientific Inc. (TMO) continues to impress investors with its strong performance in the market. With a recent rise of 3....


TMOJune 17, 2025Thermo Fisher Scientific Inc. Hits Price Target Forecast with 10.84% Profit: QuantWave Analytics  ~1 min.

Thermo Fisher Scientific Inc. (NYSE: TMO) recently achieved a price target forecast as predicted by QuantWave, resulting in a profit of 10.84%....


TMOMay 21, 2025Thermo Fisher Scientific Inc. Hits Price Target Forecast with 9.69% Profit on QuantWave Platform  ~2 min.

Thermo Fisher Scientific Inc. (TMO) recently achieved a significant milestone on QuantWave, an automated forecasting platform, by reaching the price target forecast with a 9.69% profit margin....


TMOMay 21, 2025Thermo Fisher Scientific Inc. Hits Price Target Forecast with 11.36% Profit  ~1 min.

On April 14, 2025, QuantWave's forecasting system signaled a short direction for Thermo Fisher Scientific Inc. with the stock trading at $448.86. Fast forward to May 21, 2025, the target price of $397....


TMOMay 21, 2025Thermo Fisher Scientific Inc. Price Target Forecast Achieved with 9.1% Profit: QuantWave Analysis  ~1 min.

Thermo Fisher Scientific Inc. has successfully reached the price target as forecasted by QuantWave, resulting in a 9.1% profit for investors....


TMOApril 4, 2025Thermo Fisher Scientific Inc. Stock Hits Target Forecast with 14.76% Profit Gain  ~2 min.

In an impressive display of accuracy and insight, QuantWave's forecast for Thermo Fisher Scientific Inc. stock has successfully hit its target, resulting in a profit gain of 14.76%....


TMOApril 4, 2025Thermo Fisher Scientific Inc. Hits Price Target Forecast with 17.57% Profit: A Success Story for QuantWave  ~2 min.

Thermo Fisher Scientific Inc. has recently achieved the price target forecast set by QuantWave, resulting in a profit of 17.57% for investors....


TMOApril 4, 2025Thermo Fisher Scientific Inc. Achieves Forecast Price Target with 17.14% Profit  ~2 min.

Thermo Fisher Scientific Inc. stock successfully reached the forecast price target set by QuantWave on February 28, 2025. The prediction indicated a short direction, with a price of $528....


ABTMarch 17, 2025Abbott Laboratories: A Leader in Healthcare Innovation  ~2 min.

Abbott Laboratories (NYSE: ABT) is a renowned healthcare company that has caught the attention of investors and industry experts alike....


ABTDecember 24, 2024Abbott Laboratories: A Future-Driven Pharma Brand With A Robust Pipeline  ~2 min.

Abbott Laboratories (NYSE:ABT) is a leading pharmaceutical company that continues to impress investors with its strong fundamentals and innovative product lineup....


Investing.com Analysis: Abbott Laboratories' Strong Product Lineup Indicates Promising Future  ~2 min.

Investors in Abbott Laboratories can expect a significant return on their investments in the coming years, according to a recent analysis by Investing.com....


ABTNovember 25, 2024Abbott Laboratories: A Leading Company in Healthcare  ~2 min.

Abbott Laboratories (NYSE:ABT) is a renowned healthcare company that has gained significant attention from investors....


ABTDecember 1, 2024Abbott Laboratories: A Leading Pharmaceutical Company in the Hands of Institutional Shareholders  ~1 min.

Abbott Laboratories, a renowned pharmaceutical company traded on the NYSE under the ticker symbol ABT, is currently experiencing significant control from institutional shareholders....